Moreover, we noticed a similar effect on changes in VEGFA and p-S6K1 (T389) levels: knockdown of RNF26 in ccRCC cells altered the sensitivity to palbociclib and everolimus (Supplementary Fig. 6e–h). Here, RNF26 is linked to nonpapillary renal cell carcinoma.